Latest News

Monday, May 04, 2015 | Miscellaneous

American Academy of Ophthalmology Committed to Supporting Eye Care in Nepal After Earthquake

In response to the devastating earthquake that struck Nepal on April 25, the American Academy of Ophthalmology has established the Nepal Eye Care Relief Fund. This fund will support rebuilding efforts…

Read the full story

Monday, May 04, 2015 | Clinical Trials, Eyegate Pharmaceuticals

EyeGate Pharma Receives Positive Guidance From FDA on NDA Filing Requirements of EGP-437 for the Treatment of Anterior Uveitis

Eyegate Pharmaceuticals announced receipt of comments from the FDA in response to questions submitted by the company ahead of a Type B meeting scheduled for May 5, 2015, according to a company news re…

Read the full story

Monday, May 04, 2015 | Partnerships, Clearside Biomedical , Santen

Clearside Biomedical and Santen Announce Research Collaboration in Glaucoma

Clearside Biomedical and Santen announced the expansion of their research collaboration to include the field of glaucoma. The two companies have been working together since January 2013 to develop dru…

Read the full story

Monday, May 04, 2015 | Partnerships, Shire

Shire and Foundation Fighting Blindness Announce New Research Agreement for Rare Eye Disease First Appearing in Childhood or Adolescence

Shire and the Foundation Fighting Blindness announced a new agreement focused on furthering research for a novel treatment for autosomal dominant retinitis pigmentosa (adRP), a rare genetic disease th…

Read the full story

Monday, May 04, 2015 | Clinical Trials, Allegro Ophthalmics

Allegro Ophthalmics Begins Phase 2 Clinical Study of Luminate for Non-Proliferative Diabetic Retinopathy

Allegro Ophthalmics announced that it has begun enrolling patients in a phase 2 clinical trial that will evaluate the safety and efficacy of Allegro’s first-in-class integrin peptide therapy can…

Read the full story

Monday, May 04, 2015 | Medical Studies

Study: Endothelial Cell Density is Not Significantly Different Between Diabetic and Non-Diabetic Corneas

A new study from the Lions Eye Institute for Transplant & Research (LEITR) and Montefiore Medical Center at the Albert Einstein College of Medicine finds that there is no statistically significant…

Read the full story

Monday, May 04, 2015 | Management/Leadership, Acucela

Acucela Shareholders Elect New Board Members

Acucela announced that shareholders have elected four new members to the company’s board of directors at a special meeting of the company’s shareholders, according to a company news releas…

Read the full story

Monday, May 04, 2015 | Conferences, Bausch+Lomb

Bausch + Lomb Presents New Scientific and Clinical Research During ARVO

Bausch + Lomb will present numerous scientific posters during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Denver, May 3-7, according to a company news release. Th…

Read the full story

Friday, May 01, 2015 | Product Releases, Geuder AG

Geuder Releases Brilliant Peel Dual Dye

Geuder, the maker of Brilliant Peel dye for selective staining of the internal limiting membrane, has expanded its portfolio with Brilliant Peel Dual Dye, according to a company news release. The new …

Read the full story

Friday, May 01, 2015 | Medical Studies

OCT Angiography May Better Diagnose, Manage Retinal Disease

A new study shows how optical coherence tomography (OCT) angiography can be used to visualize common retinal diseases such as diabetic retinopathy, age-related macular degeneration, and choroideremia,…

Read the full story

Friday, May 01, 2015 | Health Care

FDA to Study Safety, Effectiveness of Healthcare Antiseptics

Healthcare antiseptic products used up to 100 times a day by clinicians must prove themselves to be safe and effective, especially over the long haul, to remain on the market under proposed regulation…

Read the full story

Friday, May 01, 2015 | Conferences, Ocular Therapeutix

Ocular Therapeutix to Present Eight Posters Highlighting its Sustained-Release Hydrogel Platform Technology at ARVO

Ocular Therapeutix announced new data will be presented on the company’s sustained-release technology at the upcoming Association for Research in Vision and Ophthalmology (ARVO) annual meeting a…

Read the full story

Thursday, April 30, 2015 | Clinical Trials, AqueSys

AqueSys XEN Gel Stent Data Supporting Safety and Effectiveness Presented at ASCRS

AqueSys presented data from a number of ongoing international clinical studies on the safety and efficacy of the XEN Gel Stent in reducing IOP in glaucoma patients both independent of and in conjuncti…

Read the full story

Thursday, April 30, 2015 | Medical Studies

Trefoil Therapeutics to Present Data on Novel Class of Engineered FGF-1 Compounds at ARVO 2015 Meeting

Trefoil Therapeutics announced that David Eveleth, PhD, will present new data supporting the potential utility of engineered FGF-1s (eFGF-1s) in ocular disease at a poster at the Association for Resea…

Read the full story

Thursday, April 30, 2015 | Health Care

Pharmacists Warn of Ophthalmic Drug Shortages

New federal regulations could limit the supply of ophthalmic drugs, such as macular degeneration formulations of bevacizumab (Avastin, Genentech), report pharmacists. "I think this is going to ki…

Read the full story
Load More